AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Dupont, J Bemish, RJ McCarthy, KE Payne, ER Pollard, EB Ripin, DHB Vanderplas, BC Watrous, RM
Citation: J. Dupont et al., Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions, TETRAHEDR L, 42(8), 2001, pp. 1453-1454

Authors: Dupont, J Bemish, RJ McCarthy, KE Payne, ER Pollard, EB Ripin, DHB Vanderplas, BC Watrous, RM
Citation: J. Dupont et al., Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions (vol 42, pg 1453, 2001), TETRAHEDR L, 42(32), 2001, pp. 5587-5587

Authors: McCarthy, KE
Citation: Ke. Mccarthy, Recent advances in the design and synthesis of carbon-14 labelled pharmaceuticals from small molecule precursors, CUR PHARM D, 6(10), 2000, pp. 1057-1083

Authors: McCarthy, KE Woltering, EA Anthony, LB
Citation: Ke. Mccarthy et al., In situ radiotherapy with In-111-pentetreotide - State of the art and perspectives, Q J NUCL M, 44(1), 2000, pp. 88-95

Authors: Jones, BP Schildknegt, K Wright, KF Showell, HJ Dittami, JP McCarthy, KE Reiter, LA
Citation: Bp. Jones et al., The synthesis of an aminohexyl-containing analog of the chromanol leukotriene B-4 receptor antagonist CP-195543: A scaffold for the preparation of derivatized analogs, HETEROCYCLE, 53(8), 2000, pp. 1713

Authors: Meyers, MO Anthony, LB McCarthy, KE Drouant, G Maloney, TJ Espanan, GD Woltering, EA
Citation: Mo. Meyers et al., High-dose indium In-111 pentetreotide radiotherapy for metastatic atypicalcarcinoid tumor, SOUTH MED J, 93(8), 2000, pp. 809-811

Authors: Harrison, LH Schwarzenberger, PO Byrne, PS Marrogi, AJ Kolls, JK McCarthy, KE
Citation: Lh. Harrison et al., Gene-modified PA1-STK cells home to tumor sites in patients with malignantpleural mesothelioma, ANN THORAC, 70(2), 2000, pp. 407-411
Risultati: 1-7 |